(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

INFUGEM

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

INFUGEM

ST13

US500000087097079

Class

5

Filing

87097079

Registration

6219188

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

57

Latest update

12/16/2025

Trademark type

Word

Nice classes

5

Filing date

07/08/2016

Registration date

12/15/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/15/2020

Last transaction

12/16/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use, Foreign priority

First use anywhere

07/08/2020

First use in commerce

07/08/2020

Drawing code

4

Owner type

16

Owner location

MUMBAI, IN

Examiner

MCMORROW,JANICE LEE

Law office

M60

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Sun Pharmaceutical Industries Limited

Representatives

Craig Kuchii Sun Pharmaceutical Industries, Inc.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Medicinal and Pharmaceutical preparations packed in ready to use infusion bags for chemotherapyreduction of tension and anxietyimprovement of heart functioncorrection of hemodynamic imbalances present in the shock syndromeblood pressure control in certain acute hypotensive states and for intravenous induction of general anesthesia or before administration of other anesthetic; Medicinal and Pharmaceutical preparations packed in ready to use infusion bags for treatment of cancerpaindiseases related to central nervous systemepilepsyventricular tachycardia or ventricular fibrillationirregular heartbeatanginablood pressure and gynecological disorders

Publications

History of USPTO decisions and trademark events.

57 publications found

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

12/15/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

12/15/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

09/29/2020

PUBO

PUBLISHED FOR OPPOSITION

09/29/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

09/09/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/21/2020

AAUA

NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED

08/21/2020

XAEC

EXAMINER'S AMENDMENT ENTERED

08/20/2020

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

08/20/2020

GNEA

EXAMINERS AMENDMENT E-MAILED

08/20/2020

CNEA

EXAMINERS AMENDMENT -WRITTEN

08/20/2020

IUAA

USE AMENDMENT ACCEPTED

08/20/2020

AUPC

AMENDMENT TO USE PROCESSING COMPLETE

08/19/2020

IUAF

USE AMENDMENT FILED

08/19/2020

EAAU

TEAS AMENDMENT OF USE RECEIVED

08/18/2020

GNS2

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

06/10/2020

GNSI

INQUIRY TO SUSPENSION E-MAILED

06/10/2020

CNSI

SUSPENSION INQUIRY WRITTEN

06/10/2020

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

06/08/2020

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

11/25/2019

GNSL

LETTER OF SUSPENSION E-MAILED

11/25/2019

CNSL

SUSPENSION LETTER WRITTEN

11/25/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/25/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/25/2019

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

11/20/2019

GNS2

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

05/22/2019

GNSI

INQUIRY TO SUSPENSION E-MAILED

05/22/2019

CNSI

SUSPENSION INQUIRY WRITTEN

05/22/2019

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

05/21/2019

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

11/08/2018

GNSL

LETTER OF SUSPENSION E-MAILED

11/08/2018

CNSL

SUSPENSION LETTER WRITTEN

11/08/2018

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/06/2018

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/06/2018

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

11/02/2018

GNS2

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

05/14/2018

GNSI

INQUIRY TO SUSPENSION E-MAILED

05/14/2018

CNSI

SUSPENSION INQUIRY WRITTEN

05/14/2018

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

05/10/2018

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

11/08/2017

GNSL

LETTER OF SUSPENSION E-MAILED

11/08/2017

CNSL

SUSPENSION LETTER WRITTEN

11/08/2017

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/03/2017

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/02/2017

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

11/02/2017

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

11/02/2017

GNS2

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

05/03/2017

GNSI

INQUIRY TO SUSPENSION E-MAILED

05/03/2017

CNSI

SUSPENSION INQUIRY WRITTEN

05/03/2017

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

05/02/2017

ALIE

ASSIGNED TO LIE

05/02/2017

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

10/13/2016

GNSL

LETTER OF SUSPENSION E-MAILED

10/13/2016

CNSL

SUSPENSION LETTER WRITTEN

10/13/2016

DOCK

ASSIGNED TO EXAMINER

10/13/2016

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/13/2016

NWAP

NEW APPLICATION ENTERED

07/12/2016

Continuous trademark protection

Get notified about every new filing that threatens INFUGEM or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.